Meeting
2023 ASCO Quality Care Symposium
Reducing 30% of waiting time in the administration of antineoplastic oral drugs in patients with urological cancer.
Authors
Amaya Diaz De Cerio
Santa Bárbara Hospital, Soria, Spain
Amaya Diaz De Cerio, Carmen Marfil Peña, Hernan Alberto Rodriguez Montani, Virginia Alonso de Pablo, Maria Cruz Marron
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship
Sub Track
Coordination and Continuity of Care
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 325)
DOI
10.1200/OP.2023.19.11_suppl.325
Abstract #
325
Poster Bd #
E10
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Clinical pharmacist prescription review and modification for oral antineoplastic medications at an academic medical center.
First Author: Marina D. Kaymakcalan
Poster
2023 ASCO Quality Care Symposium
Does financial assistance reduce catastrophic spending for patients prescribed oral anti-cancer medications at an integrated Specialty Pharmacy?
First Author: Scott Swartz
Poster
2023 ASCO Quality Care Symposium
Time trends of Part D drug expenses and Part D risk adjustment in the Oncology Care Model at a community oncology network.
First Author: Puneeth Indurlal
Poster
2023 ASCO Quality Care Symposium
Non-elective inpatient anti-cancer therapy for solid tumors: To treat or not to treat?
First Author: Chloe Shevlin